Mettler-Toledo International Inc ( MTD) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.6%. By the end of trading, Mettler-Toledo International Inc rose $9.63 (6.2%) to $164.20 on average volume. Throughout the day, 471,557 shares of Mettler-Toledo International Inc exchanged hands as compared to its average daily volume of 314,800 shares. The stock ranged in a price between $153-$165.27 after having opened the day at $154 as compared to the previous trading day's close of $154.57. Other companies within the Health Care sector that increased today were: Inhibitex Inc ( INHX), up 115.7%, Idera Pharmaceuticals Inc ( IDRA), up 25.2%, Telik Inc ( TELK), up 20.4%, and AMAG Pharmaceuticals Inc ( AMAG), up 17.8%.

Mettler-Toledo International Inc. engages in the research, development, manufacture, and marketing of precision instruments and software primarily in Europe, North and South America, and Asia. Mettler-Toledo International Inc has a market cap of $4.8 billion and is part of the health services industry. The company has a P/E ratio of 20.2, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are down 0.8% year to date as of the close of trading on Thursday.

TheStreet Ratings rates Mettler-Toledo International as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, notable return on equity, good cash flow from operations and solid stock price performance. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

On the negative front, Rexahn Pharmaceuticals Inc ( RNN), down 33.4%, OxiGene Inc ( OXGN), down 33.3%, Seattle Genetics Inc ( SGEN), down 18%, and Optimer Pharmaceuticals Inc ( OPTR), down 15.4%, were all losers within the health care sector with Bristol-Myers Squibb Company ( BMY) being today's health care sector loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).